Brad Gliner

Brad joined Arcellx in March 2021, bringing over 30 years of experience in developing, testing, and commercializing medical technologies. Most recently, Brad served as VP of Clinical and Regulatory for Nevro, leading the clinical trials and regulatory approvals to bring a more effective spinal cord stimulation system to patients with chronic pain. Prior to this, Brad was VP of Research at Northstar Neuroscience, investigating numerous neuromodulation applications such as hemiparesis following stroke, major depressive disorder, movement disorders, and tinnitus. He was co-founder and Director of Research at Heartstream, which revolutionized automatic external defibrillators (AEDs), expanding their use from professional medical providers to ubiquitous availability. Brad received an M.S. degree in Biomedical Engineering from Johns Hopkins University and a B.S. in Electrical Engineering from the University of Illinois, Urbana-Champaign, IL.